The HUGO robotic-assisted surgery system showed a high surgical success rate and favorable rates of grade 3 complications. The Hugo™ robotic-assisted surgery (RAS) system is safe and effective, ...

Nephron-sparing surgery may not reduce the risk for later kidney failure in patients with kidney cancer and stage 4 CKD. Despite the promise of nephron-sparing, new study findings suggest that the ...

The probability of surgical success with telesurgery for radical prostatectomy and partial nephrectomy for small renal masses was non-inferior to local robotic surgery in a small randomized trial. The ...

Biomarker analysis from the phase 3 CheckMate 9ER trial of nivolumab + cabozantinib v sunitinib for advanced renal cell carcinoma (aRCC). Evolution of systemic therapy from 2015 to 2019 for older ...

NEW YORK, September 5, 2006 -- For forty years, the gold standard for treating a single, small tumor in the kidney has been to remove the entire kidney. A retrospective study, which appears in the ...

Since the use of vascular endothelial growth factor (VEGF)-targeted therapy became an option for frontline treatment of metastatic renal cell carcinoma (RCC) in the early 2000s, the role of ...

In a landmark moment for global healthcare, doctors from Kokilaben Dhirubhai Ambani Hospital successfully conducted a remote ...

Please provide your email address to receive an email when new articles are posted on . NASHVILLE, Tenn. — A fully automated artificial intelligence approach predicted post-nephrectomy glomerular ...